CRISPR editing in pancreatic cells reduced cell death, increased insulin secretion

With the help of the CRISPR/Cas9 gene scissors, researchers have managed to “turn off” an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells.